Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-25

Clinical Trial Update: Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease

View source ↗

Summary

This clinical trial update focuses on dynamic changes and risk factors associated with fibrosis and steatosis progression in non-alcoholic fatty liver disease. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Non-Alcoholic Fatty Liver Disease | Status: UNKNOWN